Neutrophil-to-Lymphocyte Ratio for Predicting Loss of Response to Infliximab in Ulcerative Colitis

OBJECTIVES: Neutrophil-to-lymphocyte ratio (NLR) has been used to determine the outcome in malignancies and coronary heart disease. Some reports considered the value of NLR as a predictor of response to infliximab in patients with Crohn’s disease or rheumatoid arthritis; however, no similar studies...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:PLoS One
Päätekijät: Nishida, Yu, Hosomi, Shuhei, Yamagami, Hirokazu, Yukawa, Tomomi, Otani, Koji, Nagami, Yasuaki, Tanaka, Fumio, Taira, Koichi, Kamata, Noriko, Tanigawa, Tetsuya, Shiba, Masatsugu, Watanabe, Kenji, Watanabe, Toshio, Tominaga, Kazunari, Fujiwara, Yasuhiro
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Public Library of Science 2017
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5226844/
https://ncbi.nlm.nih.gov/pubmed/28076386
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0169845
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia